IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 1 filers reported holding IGM BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $661,211 | -9.5% | 79,187 | 0.0% | 0.00% | – |
| Q2 2023 | $730,896 | +65451.2% | 79,187 | -2.4% | 0.00% | – |
| Q1 2023 | $1,115 | -21.1% | 81,169 | -2.3% | 0.00% | -100.0% |
| Q4 2022 | $1,414 | -99.9% | 83,104 | +83.9% | 0.00% | – |
| Q3 2022 | $1,027,000 | -35.0% | 45,184 | -48.5% | 0.00% | -100.0% |
| Q2 2022 | $1,581,000 | +276.4% | 87,689 | +232.0% | 0.00% | – |
| Q1 2022 | $420,000 | -40.0% | 26,412 | +10.6% | 0.00% | – |
| Q4 2021 | $700,000 | -65.6% | 23,882 | -22.9% | 0.00% | -100.0% |
| Q3 2021 | $2,035,000 | -38.2% | 30,956 | -21.8% | 0.00% | 0.0% |
| Q2 2021 | $3,295,000 | +30.8% | 39,607 | +20.5% | 0.00% | 0.0% |
| Q1 2021 | $2,520,000 | -3.7% | 32,860 | +10.9% | 0.00% | 0.0% |
| Q4 2020 | $2,616,000 | -31.7% | 29,630 | -42.9% | 0.00% | 0.0% |
| Q3 2020 | $3,828,000 | -3.9% | 51,853 | -4.9% | 0.00% | -50.0% |
| Q2 2020 | $3,982,000 | +269.4% | 54,546 | +184.2% | 0.00% | +100.0% |
| Q1 2020 | $1,078,000 | +261.7% | 19,196 | +145.5% | 0.00% | – |
| Q4 2019 | $298,000 | – | 7,818 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $97,797,000 | 2.22% |
| Artal Group S.A. | 1,500,000 | $43,995,000 | 1.19% |
| Cormorant Asset Management, LP | 500,000 | $14,665,000 | 0.87% |
| Eagle Bay Advisors LLC | 34,835 | $1,022,000 | 0.65% |
| ENTRUST GLOBAL PARTNERS L L C | 66,172 | $1,940,000 | 0.54% |
| Baker Brothers Advisors | 3,156,102 | $92,568,000 | 0.45% |
| Bruce & Co., Inc. | 55,000 | $1,613,000 | 0.32% |
| Woodline Partners LP | 403,401 | $11,832,000 | 0.17% |
| Virtus ETF Advisers LLC | 5,787 | $170,000 | 0.06% |
| Alkeon Capital Management | 939,035 | $27,542,000 | 0.05% |